A Case of Oxycodone-related Respiratory Depression Induced by Tumor Lysis Syndrome
暂无分享,去创建一个
Y. Daigo | K. Hayashi | K. Teramoto | H. Sumimoto | S. Morita | Kazuya Teramura | C. Hasegawa | Hiroaki Morii | Y. Kimura | S. Hattori
[1] H. Kokki,et al. Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone , 2019, Clinical Pharmacokinetics.
[2] S. Vig,et al. Opioid toxicity with underlying tumour lysis syndrome in a patient with CMML: a diagnostic and therapeutic challenge , 2018, BMJ Case Reports.
[3] Jessica M. Lee,et al. Pupillary Effects of High-dose Opioid Quantified with Infrared Pupillometry , 2014, Anesthesiology.
[4] B. Coiffier,et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus , 2010, British journal of haematology.
[5] C. Vachani. Tumor lysis syndrome. , 2007, Oncology.
[6] M. Kirvela,et al. The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation. , 1996, Journal of clinical anesthesia.